Keensight buys into Isto Biologics; Insight to buy Nasdaq's Solovis

Deal Wrap is updated as of 3 p.m. ET.

– Keensight Capital acquired a majority stake in Isto Biologics, a developer of orthobiologic products for spine, orthopedics and sports medicine, from Thompson Street Capital Manager LLC, which is retaining a minority stake alongside Isto Biologics’ management team. Deal value was not disclosed.

– California-based venture capital firm WndrCo Holdings LLC and other investors agreed to acquire South Africa-based Metrofile Holdings Ltd., a records and information management services provider, from various shareholders for ZAR 1.4 billion. The deal involves a cash consideration of ZAR 3.25 per share. The transaction is subject to regulatory, shareholder and court approvals, with expected completion by April 15, 2026. N M Rothschild & Sons (South Africa) (Proprietary) Limited served as financial adviser, and Webber Wentzel as legal adviser to the buyers.

– Software-focused private equity firm Insight Venture Management LLC agreed to buy Nasdaq Inc.'s financial technology platform, Solovis Inc. Financial terms were not disclosed. Solovis provides multi-asset class portfolio management, analytics, and reporting tools. The deal is expected to close in the fourth quarter.

– Disruptive Technology Advisers LLC led a $750 million funding round for Groq Inc., an AI technology company, with a post-money valuation of $6.9 billion. The round included new investor Deutsche Telekom Capital Partners Management GmbH and returning investors, including Cisco Investments and Samsung Strategy and Innovation Center. Groq plans to use the funds to enhance its position in the American AI Stack and expand its global computing capabilities.

Disclaimer: This content may be AI-assisted and is composed, reviewed, edited and approved by a human at S&P Global.

For more private equity deals, read our latest In Play report, which looks at potential private equity-backed M&A, including rumored transactions, each week.